References
- Abrahamson M, Alvarez-Fernandez M, Nathanson CM (2003). Cystatins. Biochem Soc Symp, 70, 179-99.
- Buyukberber M, Koruk I, Cykman O, et al (2010). Serum cystatin C measurement in differential diagnosis of intra and extrahepatic cholestatic diseases. Ann Hepatol, 9, 58-62.
- Calkins CC, Sloane BF (1995). Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler, 376, 71-80.
- Chen Q, Fei J, Wu L, et al (2011). Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients. Oncol Lett, 2, 693-9.
- Chu SC, Wang CP, Chang YH, et al (2004). Increased cystatin C serum concentrations in patients with hepatic diseases of various severities. Clin Chim Acta, 341, 133-8. https://doi.org/10.1016/j.cccn.2003.11.011
- Claus V, Jahraus A, Tjelle T, et al (1998). Lysosomal enzyme trafficking between phagosomes, endosomes, and lysosomes in J774 macrophages. Enrichment of cathepsin H in early endosomes. J Biol Chem, 273, 9842-51. https://doi.org/10.1074/jbc.273.16.9842
- Gatto M, Bragazzi MC, Semeraro R, et al (2010). Cholangiocarcinoma: update and future perspectives. Dig Liver Dis, 42, 253-60. https://doi.org/10.1016/j.dld.2009.12.008
- Hirai K, Yokoyama M, Asano G, et al (1999). Expression of cathepsin B and cystatin C in human colorectal cancer. Hum Pathol, 30, 680-6. https://doi.org/10.1016/S0046-8177(99)90094-1
- Iacobuzio-Donahue CA, Shuja S, Cai J, et al (1997). Elevations in cathepsin B protein content and enzyme activity occur independently of glycosylation during colorectal tumor progression. The J Biol Chem, 272, 29190-9. https://doi.org/10.1074/jbc.272.46.29190
- Kayser K, Richter N, Hufnagl P, et al (2003). Expression, proliferation activity and clinical significance of cathepsin B and cathepsin L in operated lung cancer. Anticancer Res, 23, 2767-72.
- Kos J, Nielsen HJ, Krasovec M, et al (1998). Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin Cancer Res, 4, 1511-6.
- Kos J, Stabuc B, Schweiger A, et al (1997). Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res, 3, 1815-22.
- Lazaridis KN, Gores GJ (2005). Cholangiocarcinoma. Gastroenterology, 128, 1655-67. https://doi.org/10.1053/j.gastro.2005.03.040
- Mach L, Stuwe K, Hagen A, et al (1992). Proteolytic processing and glycosylation of cathepsin B The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme. Biochem J 282, 577-82.
- Nagai A, Terashima M, Harada T, et al (2003). Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis. Clin Chim Acta, 329, 53-60. https://doi.org/10.1016/S0009-8981(03)00023-8
- Sayasone S, Odermatt P, Phoumindr N, et al (2007). Epidemiology of Opisthorchis viverrini in a rural district of southern Lao PDR. Trans R Soc Trop Med Hyg, 101, 40-7. https://doi.org/10.1016/j.trstmh.2006.02.018
- Sloane BF (1990). Cathepsin B and cystatins: evidence for a role in cancer progression. Semin Cancer Biol, 1, 137-52.
- Sripa B, Bethony JM, Sithithaworn P, et al (2011). Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop, 120, 158-68. https://doi.org/10.1016/j.actatropica.2010.07.006
- Strojan P, Svetic B, Smid L, et al (2004). Serum cystatin C in patients with head and neck carcinoma. Clin Chim Acta, 344, 155-61. https://doi.org/10.1016/j.cccn.2004.02.011
- Tsai HT, Wang PH, Tee YT, et al (2009). Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease. Fertil Steril, 91, 549-55. https://doi.org/10.1016/j.fertnstert.2007.12.076
- Uchiyama H, Anderson KC (1994). Cellular adhesion molecules. Transfus Med Rev, 8, 84-95. https://doi.org/10.1016/S0887-7963(94)70101-2
- Wongkham S, Silsirivanit A (2012). State of serum markers for detection of cholangiocarcinoma. Asian Pac J Cancer Prev, 13, 17-27.
- Yang X, Wei KJ, Zhang L, et al (2010). Increased expression of Cathepsin B in oral squamous cell carcinoma. Int J Oral Maxillofac Surg, 39, 174-81. https://doi.org/10.1016/j.ijom.2009.11.018
Cited by
- Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients vol.15, pp.1, 2016, https://doi.org/10.1186/s12943-016-0503-9
- Potential Roles of Protease Inhibitors in Cancer Progression vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8047
- Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma vol.108, pp.11, 2017, https://doi.org/10.1111/cas.13396
- Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review vol.98, pp.6, 2018, https://doi.org/10.4269/ajtmh.17-0879